Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions.
Investors 1
| Date | Name | Website |
| - | Vivo Capit... | vivocapita... |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 30.08.2021 | Trevena : ... | CHESTERBROOK, Penn., Aug. 30, ... | - | - | marketscre... |
| 10.08.2021 | Trevena : ... | CHESTERBROOK, Pa., Aug. 10, 20... | - | - | marketscre... |
| 12.07.2021 | Trevena : ... | Models demonstrate substantial... | - | - | marketscre... |
| 12.05.2021 | TREVENA, I... | -- Elderly and obese patients... | - | - | marketscre... |
| 06.05.2021 | TREVENA, I... | -- Company reaffirms YE targe... | - | - | marketscre... |
| 15.04.2021 | TREVENA, I... | -- Models demonstrate substan... | - | - | marketscre... |
| 02.11.2018 | Trevena h... | The FDA evidently managed ... | - | John Carro... | endpts.com... |
| 29.06.2016 | The biotec... | There was a time after the 20... | Financing | John Carro... | endpts.com... |